Therapeutic Effect of Cytoreductive Radical Prostatectomy in Men With Newly Diagnosed Metastatic Prostate Cancer

NCT03456843 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Prostate Adenocarcinoma AJCC v7

Interventions

DRUG: Antiandrogen Therapy
DRUG: Docetaxel
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Quality-of-Life Assessment
OTHER: Questionnaire Administration
PROCEDURE: Radical Prostatectomy

Sponsor

Yale University

Collaborators

National Cancer Institute (NCI)